News
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results